Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naoto Sassa

Showing results (41-50 of 85) with videos related to

Pageof 9
Sort By:
Cancer Chemotherapy and Pharmacology|September 3, 2016
Association of axitinib plasma exposure and genetic polymorphisms of ABC transporters with axitinib-induced toxicities in patients with renal cell carcinomaHiroshi Kato, Naoto Sassa, Masayuki Miyazaki, et al.
International Journal of Clinical Oncology|September 22, 2020
UroVysion<sup>®</sup> predicts intravesical recurrence after radical nephroureterectomy for urothelial carcinoma of the upper urinary tract: a prospective studyHidehiro Iwata, Naoto Sassa, Masashi Kato, et al.
Japanese Journal of Clinical Oncology|July 24, 2020
Characteristics of primary and repeated recurrent retroperitoneal liposarcoma: outcomes after aggressive surgeries at a single institutionKenta Ishii, Yukihiro Yokoyama, Yoshihiro Nishida, et al.
Pathology International|August 23, 2023
PTEN loss in intraductal carcinoma of the prostate has low incidence in Japanese patientsTakanori Ito, Taishi Takahara, Natsuki Taniguchi, et al.
International Journal of Clinical Oncology|January 18, 2020
Clinical characteristics and surgical outcomes of retroperitoneal tumors: a comprehensive data collection from multiple departmentsNaoto Sassa, Yukihiro Yokoyama, Yoshihiro Nishida, et al.
American Journal of Clinical Pathology|January 23, 2019
Diagnostic Utility of UroVysion Combined With Conventional Urinary Cytology for Urothelial Carcinoma of the Upper Urinary TractNaoto Sassa, Hidehiro Iwata, Masashi Kato, et al.
Cancer Chemotherapy and Pharmacology|May 11, 2015
Extension of the Calvert formula to patients with severe renal insufficiencyTomoyo Oguri, Tomoya Shimokata, Isao Ito, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 25, 2010
Renal cell carcinomas in haemodialysis patients: does haemodialysis duration influence pathological cell types and prognosis?Naoto Sassa, Ryohei Hattori, Toyonori Tsuzuki, et al.
Molecular and Clinical Oncology|December 1, 2016
Muscle wasting associated with the long-term use of mTOR inhibitorsBishal Gyawali, Tomoya Shimokata, Kazunori Honda, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|September 14, 2020
Presence of constipation predicts the therapeutic efficacy of pembrolizumab in metastatic urothelial cancer patientsSatoshi Inoue, Naoto Sassa, Takashi Kato, et al.
Pageof 9

Showing results (41-50 of 85) with videos related to

Sort By:
Pageof 9
Cancer Chemotherapy and Pharmacology|September 3, 2016
Association of axitinib plasma exposure and genetic polymorphisms of ABC transporters with axitinib-induced toxicities in patients with renal cell carcinomaHiroshi Kato, Naoto Sassa, Masayuki Miyazaki, et al.
International Journal of Clinical Oncology|September 22, 2020
UroVysion<sup>®</sup> predicts intravesical recurrence after radical nephroureterectomy for urothelial carcinoma of the upper urinary tract: a prospective studyHidehiro Iwata, Naoto Sassa, Masashi Kato, et al.
Japanese Journal of Clinical Oncology|July 24, 2020
Characteristics of primary and repeated recurrent retroperitoneal liposarcoma: outcomes after aggressive surgeries at a single institutionKenta Ishii, Yukihiro Yokoyama, Yoshihiro Nishida, et al.
Pathology International|August 23, 2023
PTEN loss in intraductal carcinoma of the prostate has low incidence in Japanese patientsTakanori Ito, Taishi Takahara, Natsuki Taniguchi, et al.
International Journal of Clinical Oncology|January 18, 2020
Clinical characteristics and surgical outcomes of retroperitoneal tumors: a comprehensive data collection from multiple departmentsNaoto Sassa, Yukihiro Yokoyama, Yoshihiro Nishida, et al.
American Journal of Clinical Pathology|January 23, 2019
Diagnostic Utility of UroVysion Combined With Conventional Urinary Cytology for Urothelial Carcinoma of the Upper Urinary TractNaoto Sassa, Hidehiro Iwata, Masashi Kato, et al.
Cancer Chemotherapy and Pharmacology|May 11, 2015
Extension of the Calvert formula to patients with severe renal insufficiencyTomoyo Oguri, Tomoya Shimokata, Isao Ito, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 25, 2010
Renal cell carcinomas in haemodialysis patients: does haemodialysis duration influence pathological cell types and prognosis?Naoto Sassa, Ryohei Hattori, Toyonori Tsuzuki, et al.
Molecular and Clinical Oncology|December 1, 2016
Muscle wasting associated with the long-term use of mTOR inhibitorsBishal Gyawali, Tomoya Shimokata, Kazunori Honda, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|September 14, 2020
Presence of constipation predicts the therapeutic efficacy of pembrolizumab in metastatic urothelial cancer patientsSatoshi Inoue, Naoto Sassa, Takashi Kato, et al.
Pageof 9